Delcath Systems plans to issue 5 million shares in a public offering

Jefferies is bookrunner; deal comes with greenshoe for 15% more

By Susanna Moon

Chicago, July 14 - Delcath Systems, Inc. plans to sell 5 million of common shares in a public offering, according to a 424B5 filing with the Securities and Exchange Commission. Jefferies & Co., Inc. is the bookrunner.

The company's shares closed at $6.28 (Nasdaq: DCTH) on July 13.

There is an over-allotment option for another 750,000 shares.

Proceeds will be used for general corporate purposes, including obtaining regulatory approvals, product commercialization, funding of clinical trials, capital expenditures and working capital.

Delcath is a New York-based development-stage company that has developed a system designed to administer high-dose chemotherapy and other therapeutic agents to diseased organs or regions of the body.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.